pharmaphorum

PTC pulls file for Duchenne therapy on FDA feedback

PTC Therapeutics has abandoned its latest attempt to secure FDA approval for Duchenne muscular dystrophy (DMD) treatment Translarna, after the FDA said it was unlikely to approve the drug based on the ...
pharmaphorum

PTC's Huntington study was positive. Why did its stock fall?

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...
Barron's

PTC Inc.

PTC, Inc. is a global software company. Its products include Windchill, Creo, ThingWorx, Vuforia, Codebeamer, Arbortext, Arena, and Onshape. The company was founded ...
Mint

Mutual Fund Ownership

Explore list of mutual funds that have invested in & analyse the ownership details to gain insights. Motilal Oswal Large and Midcap Fund Regular Growth 5/5 3.42 370.62 Motilal Oswal ELSS Tax Saver ...